Inhibition of recombinant SARS CoV-1 main protease expressed using MCA-AVLQSGFR-K(DNP)-K-NH2 as substrate at 10 uM incubated for 2 hrs by FRET based a...

Basic Information

ID: ALA5136660

Type: Binding

Description: Inhibition of recombinant SARS CoV-1 main protease expressed using MCA-AVLQSGFR-K(DNP)-K-NH2 as substrate at 10 uM incubated for 2 hrs by FRET based assay

Format: BAO_0000019

Organism: Severe acute respiratory syndrome-related coronavirus

Target: Unchecked(ALA612545)

Document: ALA5131566

Inhibition of recombinant SARS CoV-1 main protease expressed using MCA-AVLQSGFR-K(DNP)-K-NH2 as substrate at 10 uM incubated for 2 hrs by FRET based assay: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA5136660

Inhibition

Total(7)

Parent Molecular Weight	ALogP	Polar Surface Area
255.30	2.89	2.89
267.31	2.96	2.96
286.38	3.93	3.93
275.36	3.26	3.26
261.33	2.95	2.95
269.33	3.20	3.20
326.40	3.77	3.77

Parent Molecular Weight

ALogP

Polar Surface Area

255.30

2.89

267.31

2.96

286.38

3.93

275.36

3.26

261.33

2.95

269.33

3.20

326.40

3.77

Inhibition of recombinant SARS CoV-1 main protease expressed using MCA-AVLQSGFR-K(DNP)-K-NH2 as substrate at 10 uM incubated for 2 hrs by FRET based a...

Basic Information

Activity Charts

Compound Summary